The longer an individual is paralyzed, the more at-risk he or she is to osteoporosis, a condition which endangers our bones. Early treatment is the key.
Older women and men with prostate cancer were tested with a new, genetically engineered drug called denosumab, made by Amgen. It will be reviewed this next week by FDA advisers. READ MORE
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.